Impact of estrogen receptor levels on outcome in non-metastatic triple negative breast cancer patients treated with neoadjuvant/adjuvant chemotherapy

Although 1% is the recommended cut-off to define estrogen receptor (ER) positivity, a 10% cut-off is often used in clinical practice for therapeutic purposes. We here evaluate clinical outcomes according to ER levels in a monoinstitutional cohort of non-metastatic triple-negative breast cancer (BC)...

Descripción completa

Detalles Bibliográficos
Autores principales: Dieci, Maria Vittoria, Griguolo, Gaia, Bottosso, Michele, Tsvetkova, Vassilena, Giorgi, Carlo Alberto, Vernaci, Grazia, Michieletto, Silvia, Angelini, Silvia, Marchet, Alberto, Tasca, Giulia, Genovesi, Elisa, Cumerlato, Enrico, Lo Mele, Marcello, Conte, PierFranco, Guarneri, Valentina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8329161/
https://www.ncbi.nlm.nih.gov/pubmed/34341356
http://dx.doi.org/10.1038/s41523-021-00308-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8329161/
https://www.ncbi.nlm.nih.gov/pubmed/34341356
http://dx.doi.org/10.1038/s41523-021-00308-7

Ejemplares similares